MedTrace Logo

Sentinel Node Detection in Endometrial Cancer: A Consolidation Study on Detection Rates of Metastatic Disease

NCT03838055 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 362

Last updated 2019-02-12

No results posted yet for this study

Summary

Evaluation of removal of Sentinel lymph nodes only for detection of pelvic lymph node metastases in high risk and low risk endometrial cancer.

Conditions

Interventions

PROCEDURE

Injection of tracer ( ICG) and detection of sentinel lymph nodes

Pelvic SLN's defined by ICG injected cervically

Sponsors & Collaborators

  • Region Skane

    lead OTHER

Principal Investigators

  • Jan Persson, Ass Prof · RegionSkane, department of OB&G, Skåne university hospital, Lund

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-28
Primary Completion
2022-12-31
Completion
2023-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03838055 on ClinicalTrials.gov